The abstract is read at the publisher; the summary is JClub's.
Simeprevir suppresses KPNB1-mediated nuclear import of p65, downregulating Bcl-2 and inducing mitochondrial apoptosis in multiple cancer cell lines and A549 xenografts.
- Why it matters: Cancer cells can rely on nuclear protein localization for survival, but KPNB1’s oncogenic mechanism and druggability are not well defined.
- What they did: Screening an FDA-approved compound library identified simeprevir and lusutrombopag as direct KPNB1 inhibitors that disrupt import complex assembly and block p65 nuclear import.
- The result: Sim induced apoptosis by lowering Bcl-2, reversed by KPNB1/p65/Bcl-2 overexpression (not NLS-deleted p65), suppressed A549 xenograft growth, and TCGA data support the KPNB1–p65–Bcl-2 axis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.